ArticleBMC health services research2026
Determinants of out-of-pocket expenditures amongst cancer patients undergoing modern radiotherapy modalities in public healthcare facilities of Tamil Nadu, South India.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe advancement of medical technology has improved cancer treatment, yet financial disparities remain, particularly in low-income regions. Modern radiotherapy modalities, including LINAC, Cobalt Therapy, and Brachytherapy, impose significant Out-Of-Pocket Expenditure (OOPE) on patients despite public healthcare provisions. This study aims to assess OOPE and its determinants among patients undergoing advanced radiotherapy in public healthcare facilities in Tamil Nadu.
methodsA cross-sectional study was conducted in secondary and tertiary hospitals across Tamil Nadu, enrolling 500 patients undergoing radiotherapy. Patient-level costing included direct medical costs (procedure, material), direct non-medical costs (travel, accommodation, food), and indirect costs (income loss for patients and caregivers). Log-linear regression models in STATA 17 identified key OOPE determinants, including socioeconomic status, insurance coverage, travel distance, and waiting time.
resultsWhile procedural costs were covered under insurance, non-medical and indirect costs significantly contributed to OOPE. The median total per-patient cost per radiotherapy procedure was ₹900 for LINAC, ₹840 for cobalt therapy, and ₹1,550 for brachytherapy. Higher socioeconomic status and greater travel distances increased expenditures. Patients who were insured but did not utilize insurance faced catastrophic expenses (₹55,900 median cost), highlighting gaps in awareness and accessibility.
conclusionDespite insurance coverage, financial burdens persist, necessitating targeted interventions. Strengthening insurance utilization, decentralizing radiotherapy services, and integrating patient support systems can reduce OOPE. Future research should explore long-term financial interventions to improve equitable cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.